TMCnet News
Research and Markets: Global Dyslipidemia Epidemiology and Patient Flow Analysis 2015Research and Markets (http://www.researchandmarkets.com/research/8nfhdp/global) has announced the addition of the "Global Dyslipidemia Epidemiology and Patient Flow Analysis - 2015" report to their offering. The report provides insights into Dyslipidemia epidemiology, Dyslipidemia diagnosed patients, and Dyslipidemia treatment rate for top seven pharmaceutical markets. The study measures key indicators such as prevalence of Dyslipidemia derived from epidemiological analysis, percentage of patients diagnosed with Dyslipidemia, and percentage of patients treatd with Dyslipidemia therapy. The study helps executives estimate Dyslipidemia market potential, assess unmet need, develop drug forecasting models, and build population-based health management frameworks. The information presented in this study is used to evaluate market opportunities, effectively identify target patient population, and align marketing decisions. The report provides estimates and forecasts of Dyslipidemia prevalence, Dyslipidemia diagnosis rate, and Dyslipidemia treatment rate for the period 2014 - 2020. The information is presented by leading geographies including the US, Germany, France, Spain, Italy, UK, and Japan. Key Topics Covered: 1. Dyslipidemia: Disease Definition 2. Global Dyslipidemia Patient Flow 3. Dyslipidemia Patient Flow in the US 4. Dyslipidemia Patient Flow in Europe 5. Dyslipidemia Patient Flow in Germany 6. Dyslipidemia Patient Flow in France 7. Dyslipidemia Patient Flow in Spain 8. Dyslipidemia Patient Flow in Italy 9. Dyslipidemia Patient Flow in UK 10. Dyslipidemia Patient Flow in Japan 11. Appendix For more information visit http://www.researchandmarkets.com/research/8nfhdp/global |
